blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3734283

EP3734283 - APPLICATIONS OF BIOMARKER IN TERMS OF DETERMINING ANTIPHOSPHOLIPID SYNDROME AND REAGENT KIT OF BIOMARKER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.04.2024
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  12.05.2023
FormerGrant of patent is intended
Status updated on  08.01.2023
FormerExamination is in progress
Status updated on  05.11.2021
FormerRequest for examination was made
Status updated on  02.10.2020
FormerThe international publication has been made
Status updated on  19.07.2019
Most recent event   Tooltip12.07.2024Lapse of the patent in a contracting state
New state(s): IE		published on 14.08.2024  [2024/33]
Applicant(s)For all designated states
GUANGZHOU KANGRUN BIOTECHNOLOGY CO., LTD
Room 601A, Buliding 2, No. 8, Dengyun Road
Tangbudong Village, Nancun Town, Panyu District
Guangzhou, Guangdong 511442 / CN
[2023/24]
Former [2020/45]For all designated states
GUANGZHOU KANGRUN BIOTECHNOLOGY CO., LTD
Room 601A, Buliding 2, No. 8, Dengyun Road
Tangbudong Village, Nancun Town, Panyu District
Guangzhou, Guangdong 511442 / CN
Inventor(s)01 / YANG, Chengde
Room 601A, Buliding 2, No. 8, Dengyun Road
Tangbudong Village, Nancun Town, Panyu District
Guangzhou, Guangdong 511442 / CN
02 / SHI, Hui
Room 601A, Buliding 2, No. 8, Dengyun Road
Tangbudong Village, Nancun Town, Panyu District
Guangzhou, Guangdong 511442 / CN
03 / HUANG, Wenxi
Room 601A, Buliding 2, No. 8, Dengyun Road
Tangbudong Village, Nancun Town, Panyu District
Guangzhou, Guangdong 511442 / CN
 [2020/45]
Representative(s)Monteiro Alves, Inês
Alameda Dos Oceanos, Nº 41K-21
Parque das Nações
1990-207 Lisboa / PT
[2023/24]
Former [2020/45]Sun, Yiming
HUASUN Patent- und Rechtsanwälte
Friedrichstraße 33
80801 München / DE
Application number, filing date18899192.110.07.2018
[2020/45]
WO2018CN95067
Priority number, dateCN2018103085212.01.2018         Original published format: CN201810030852
[2020/45]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019136948
Date:18.07.2019
Language:ZH
[2019/29]
Type: A1 Application with search report 
No.:EP3734283
Date:04.11.2020
Language:EN
[2020/45]
Type: B1 Patent specification 
No.:EP3734283
Date:14.06.2023
Language:EN
[2023/24]
Search report(s)International search report - published on:CN18.07.2019
(Supplementary) European search report - dispatched on:EP02.02.2021
ClassificationIPC:G01N33/68, G01N33/48, G01N33/53, G01N21/76, G01N33/564
[2021/09]
CPC:
G01N33/564 (EP); G01N33/6854 (CN,US); G01N33/6893 (CN,US);
G01N21/76 (EP,CN,US); G01N33/48 (CN); G01N33/53 (CN);
G01N2333/4712 (EP); G01N2800/26 (EP); G01N2800/32 (CN,US) (-)
Former IPC [2020/45]G01N33/68, G01N33/48, G01N33/53, G01N21/76
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/45]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ANWENDUNGEN VON BIOMARKERN ZUR BESTIMMUNG DES ANTIPHOSPHOLIPID-SYNDROMS UND REAGENZIENKIT FÜR BIOMARKER[2020/45]
English:APPLICATIONS OF BIOMARKER IN TERMS OF DETERMINING ANTIPHOSPHOLIPID SYNDROME AND REAGENT KIT OF BIOMARKER[2020/45]
French:APPLICATIONS D'UN BIOMARQUEUR PAR RAPPORT À LA DÉTERMINATION DU SYNDROME DES ANTIPHOSPHOLIPIDES ET KIT DE RÉACTIFS DE BIOMARQUEUR[2020/45]
Entry into regional phase31.07.2020Translation filed 
31.07.2020National basic fee paid 
31.07.2020Search fee paid 
31.07.2020Designation fee(s) paid 
31.07.2020Examination fee paid 
Examination procedure31.07.2020Examination requested  [2020/45]
20.07.2021Amendment by applicant (claims and/or description)
05.11.2021Despatch of a communication from the examining division (Time limit: M04)
28.02.2022Reply to a communication from the examining division
06.07.2022Despatch of a communication from the examining division (Time limit: M04)
03.11.2022Reply to a communication from the examining division
09.01.2023Communication of intention to grant the patent
28.04.2023Receipt of the translation of the claim(s)
02.05.2023Fee for grant paid
02.05.2023Fee for publishing/printing paid
Opposition(s)15.03.2024No opposition filed within time limit [2024/21]
Fees paidRenewal fee
31.07.2020Renewal fee patent year 03
08.06.2021Renewal fee patent year 04
06.06.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ14.06.2023
ES14.06.2023
HR14.06.2023
MC14.06.2023
PL14.06.2023
RO14.06.2023
RS14.06.2023
SK14.06.2023
SM14.06.2023
IE10.07.2023
CH31.07.2023
NO14.09.2023
GR15.09.2023
IS14.10.2023
[2024/33]
Former [2024/25]CZ14.06.2023
ES14.06.2023
HR14.06.2023
MC14.06.2023
PL14.06.2023
RO14.06.2023
RS14.06.2023
SK14.06.2023
SM14.06.2023
CH31.07.2023
NO14.09.2023
GR15.09.2023
IS14.10.2023
Former [2024/16]CZ14.06.2023
ES14.06.2023
HR14.06.2023
MC14.06.2023
PL14.06.2023
RO14.06.2023
RS14.06.2023
SK14.06.2023
SM14.06.2023
NO14.09.2023
GR15.09.2023
IS14.10.2023
Former [2024/10]CZ14.06.2023
ES14.06.2023
HR14.06.2023
PL14.06.2023
RO14.06.2023
RS14.06.2023
SK14.06.2023
SM14.06.2023
NO14.09.2023
GR15.09.2023
IS14.10.2023
Former [2024/08]ES14.06.2023
HR14.06.2023
RS14.06.2023
SK14.06.2023
SM14.06.2023
NO14.09.2023
GR15.09.2023
Former [2023/51]ES14.06.2023
HR14.06.2023
RS14.06.2023
NO14.09.2023
GR15.09.2023
Former [2023/50]ES14.06.2023
NO14.09.2023
GR15.09.2023
Former [2023/48]ES14.06.2023
NO14.09.2023
Former [2023/46]ES14.06.2023
Documents cited:Search[A]US5998223  (MATSUURA EIJI [JP], et al) [A] 1-6 * the whole document *;
 [A]WO2005054853  (GLYCOMINDS LTD [IL], et al) [A] 1-6 * the whole document *;
 [A]US2010261194  (YU GUO-LIANG [US], et al) [A] 1-6* the whole document *;
 [A]WO2010121714  (DIAMETRA S R L [IT], et al) [A] 1-6 * the whole document *;
 [A]WO2011022780  (SOUTH EASTERN SYDNEY AND ILLAWARRA AREA HEALTH SERVICE [AU], et al) [A] 1-6 * the whole document *;
 [Y]WO2013006156  (INOVA DIAGNOSTICS INC [US], et al) [Y] 1-6 * whole document, in particular claim 1; par. 54 *;
 [Y]WO2017194779  (SERVIZO GALEGO DE SAÚDE (SERGAS) [ES], et al) [Y] 1-6 * whole document, in particular p.13, l. 15-33, p. 14, l. 11, p. 15, l. 10 *;
 [Y]  - MALIN ?STENSSON ET AL, "A Possible Mechanism behind Autoimmune Disorders Discovered By Genome-Wide Linkage and Association Analysis in Celiac Disease", PLOS ONE, (20130802), vol. 8, no. 8, doi:10.1371/journal.pone.0070174, page e70174, XP055343972 [Y] 1-6 * whole document, in particular p. 5, col. 2, full par. 5; p. 9, col. 2, full par. 1 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0070174
International search[A]CN206489172U  (TIANJIN BAIAISEN BIOTECHNOLOGY CO LTD) [A] 1-10;
 [PX]CN108226534  (GUANGZHOU KANGRUN BIOLOGICAL TECH CO LTD) [PX] 1-10;
 [X]  - HAN Haibo et al., "Preparation and identification of mouse anti-human myosin va polyclonal antibody", Chinese Journal of Cellular and Molecular Immunology, (20050518), vol. 25, no. 5, doi:10.13423/j.cnki.cjcmi.005016, ISSN 1007-8738, pages 451 - 453, XP009522459 [X] 7-10

DOI:   http://dx.doi.org/10.13423/j.cnki.cjcmi.005016
 [A]  - Venkaiah Betapudi , George Lominadze , Linda Hsi , Belinda Willard , Meifang Wu , Keith R McCrae, "Anti-beta 2GPI antibodies stimulate endothelial cell mi-croparticle release via a non-muscle myosin II motor protein-dependent pathway", Blood, (20130828), vol. 122, no. 23, doi:10.1182/blood-2013-03-490318, pages 3808 - 3817, XP055625069 [A] 1-10 * , *

DOI:   http://dx.doi.org/10.1182/blood-2013-03-
ExaminationWO2017122203
    - YAMAZAKI REIJI ET AL, "Expression of Unconventional Myosin VI in Oligodendrocytes", NEUROCHEMICAL RESEARCH, PLENUM PRESS, NEW YORK, US, vol. 42, no. 12, doi:10.1007/S11064-017-2377-7, ISSN 0364-3190, (20170821), pages 3372 - 3381, (20170821), XP036365055

DOI:   http://dx.doi.org/10.1007/s11064-017-2377-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.